henhaobio
Sign in

Molecular PharmacologyNeurosciencePeer-reviewed journal article

The CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding

Matthew E. LarseniD, C. Madison BarkeriD, Raul Satoshi VargasiD, Steven J. CoultrapiD, Karl Ulrich BayeriD

PDFDOIPreprint

Abstract

Three recent studies claimed that induction of long-term potentiation (LTP) of synaptic strength requires structural rather than enzymatic functions of the Ca2+/Calmodulin(CaM)-dependent protein kinase II (CaMKII). One study utilized the CaMKII D135N mutation, which was claimed to abolish enzymatic activity without affecting the structural function, i.e. binding to GluN2B. We found here that the D135N mutant indeed abolished enzymatic kinase activity and autophosphorylation at T286 (pT286). However, D135N mutation additionally reduced binding to GluN2B and prevented persistence of co-condensation with GluN2B. Similar as with the T286A mutant, GluN2B binding of the D135N mutant could be partially rescued by AS283, an inhibitor that directly enhances GluN2B binding. This partial effect on GluN2B binding has to be taken into account when using D135N to distinguish between enzymatic versus structural functions of CaMKII. Nonetheless, as discussed here, the D135N mutant indeed supports a structural rather than enzymatic CaMKII function in LTP induction.

Citations
0
FWCI
0.00
Field percentile
1th percentile

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.